Integrative genetic and functional characterization of treatment-associated clonal evolution in hr-MDS and sAML

被引:0
|
作者
Mazzeo, P. [1 ]
Ganster, C. [1 ]
Koch, R. [2 ]
Haase, D. [1 ]
机构
[1] Univ Med Ctr Gottingen UMG, Clin Hematol & Med Oncol, INDIGHO Lab, Gottingen, Germany
[2] Univ Med Ctr Gottingen UMG, Dept Hematol & Med Oncol, Gottingen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
V872
引用
收藏
页码:124 / 125
页数:2
相关论文
共 5 条
  • [1] Characterization of Somatic Mosaicism and Mutational Profiling of Clonal Hematopoiesis Compared to MDS and sAML Depicts Diversities of Clonal Evolution
    Hecker, Judith S.
    Hartmann, Luise
    Rothenberg-Thurley, Maja
    Riviere, Jennifer
    Ksienzyk, Bianka
    Buck, Michele C.
    Van Der Garde, Mark
    Fischer, Luise
    Winter, Susann
    Rauner, Martina
    Tsourdi, Elena
    Sockel, Katja
    Schneider, Marie
    Kubasch, Anne Sophie
    Nolde, Martin
    Hausmann, Dominikus
    Luetzner, Joerg
    Roth, Andreas
    Bassermann, Florian
    Spiekermann, Karsten
    Hofbauer, Lorenz
    Platzbecker, Uwe
    Metzeler, Klaus H.
    Goetze, Katharina S.
    BLOOD, 2021, 138
  • [2] A SYSTEMATIC LITERATURE REVIEW (SLR) OF THE CLINICAL EFFICACY AND SAFETY EVIDENCE ASSOCIATED WITH TREATMENT OF PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME (HR-MDS)
    Papadakis-Sali, A.
    Bobrowska, A.
    Shaw, S.
    Radford, M.
    Estrella, Sabate E. J.
    Asukai, Y.
    VALUE IN HEALTH, 2023, 26 (12) : S18 - S19
  • [3] Clinical outcomes associated with azacitidine (AZA) monotherapy for treatment-naive, higher-risk myelodysplastic syndrome (HR-MDS): A systematic literature review and meta-analysis.
    Hasegawa, Ken
    Wei, Andrew H.
    Garcia-Manero, Guillermo
    Daver, Naval Guastad
    Rajakumaraswamy, Nishanthan
    Iqbal, Shahed
    Chan, Rebecca J.
    Hu, Hao
    Tse, Preston
    Yan, Jiajun
    Zoratti, Michael J.
    Xie, Feng
    Sallman, David Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: Integration and evolution of genetic diagnosis
    Di Taranto, M. D.
    D'Agostino, M. N.
    Fortunato, G.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2015, 25 (11) : 979 - 987
  • [5] BMS-986397, a First-in-Class Molecular Glue Degrader of Casein Kinase 1α (CK1α) for the Treatment of Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS) Harboring Functional TP53
    Jimenez, Carmen
    Peng, Sophie
    Narla, Rama Krishna
    Baughman, Joshua
    Wood, Scott
    Lu, Jean
    Purroy, Noelia
    Yanochko, Gina
    Nagy, Mark
    Lu, Gang
    Rolfe, Mark
    Pierce, Daniel W.
    Carrancio, Soraya
    BLOOD, 2024, 144 : 4142 - 4143